• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

P
Pabinger I	-	High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma
	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
	-	High Levels of Anti-protein Z Immunoglobulin G and M Antibodies, Persistent Lupus Anticoagulant and Thrombosis
	-	Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH)
	-	Combinatorial Peptides Directed to Inhibitory Antibodies against Human Blood Clotting Factor VIII
	-	Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures
	-	Thrombophilia and Pregnancy Outcomes
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
Paccamiccio E	-	Validation of Laboratory Reference Standards for Clinical Use of INR-POC Devices: A Randomized Multicentre Exercise
	-	Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Pachmann U	-	Acquired Glanzmann's Thrombasthenia Associated with Trastuzumab (Herceptin®) Therapy: A Case Report
Pacini G	-	Insulin Resistance and Platelet Activation in Obese Women
Packham MA	-	Clearance of Procoagulant Platelet-Derived Microparticles from the Circulation of Rabbits
Pacquola E	-	Prevalence of Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients Wwith Immune Thrombocytopenic Purpura (ITP)
Pacurar RM	-	Thrombotic Risk in a Romanian Family with Protein S: Deficient Members
Padeletti L	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Padjas A	-	Kinetics of Thrombin Formation at the Site of Microvascular Injury: Effects of Coagulation Factors and Oral Anticoagulation
	-	Factor VIII Levels and Blood Coagulation in Patients on Long-Term Oral Anticoagulation (OA)
Padmanabhan N	-	Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
Padrazzi B	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Padrini R	-	How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
Paganelli R	-	Determinants of Platelet Activation in Alzheimer's Disease
Paglieroni TJ	-	Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients
Pagnan A	-	Cerebral Sinovenous Thrombosis in Children
	-	Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients
	-	Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
	-	How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
	-	Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants
	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
	-	Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
	-	Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects
	-	Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study)
	-	Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study
	-	Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (‘Parahaemophilia’): Report of a Novel Homozygous Mutation (FV: Asp524His)
	-	Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study
	-	The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study
	-	A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
	-	FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
Pagnini P	-	eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
Pagès J	-	Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor
Pai M	-	A System to Track Coagulation Factor Concentrates Can Decrease Waste
	-	Telephone Consultation Provided by the Hemophilia Treatment Centre – A Significant Part of the Service
Pai KM	-	Immune Tolerance to Factor IX inhibitor
	-	Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B
Paiva EF	-	Systematic Review of Risk Factors for Venous Thromboembolism in Hospitalized Medical Patients and Recommendations for Prophylaxis Implementation by a Multidisciplinary Group
Paladino E	-	Long Term and Low Dose Prophylaxis with rFVIIa in Patients Affected by Congenital Bleeding Disorders
Palafox-Sánchez C	-	Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis
Palareti G	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
	-	Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
	-	D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
	-	A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
Palareti G	-	The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
Palareti G	-	D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
Palareti G	-	Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels
Palareti G	-	Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal
Palascak J	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Palazzo A	-	Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Palazzuoli A	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Palencia MA	-	Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease
Paleolog E	-	Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
Palermo M	-	Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents
Palkovits J	-	Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
Palla R	-	Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain
Palla R	-	Ristocetin Accelerates Von Willebrand Factor (VWF) Hydrolysis Rate and Ameliorates Collagen Binding Assay (CBA) Sensitivity
Palla R	-	Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13
Palma M	-	Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment
Palmarini MFG	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
Palmer L	-	Correlation Between Compresive Ultrasonography and D Dimer Levels in Patients with Deep Venous Thrombosis
Palmerini F	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Palmieri N	-	Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures
Palmieri V	-	Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary
Palosuo T	-	Acquired and Hereditary Thrombophilia and Recurrent Miscarriage
Palumbo L	-	Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion
Paluszkiewicz A	-	The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction
Pampuch A	-	The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients
Pan X-Y	-	Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance
Pan X-y	-	Alteration of Protein Z in Malignant Tumors and Its Significance
Pan X-Y	-	Alteration of Protein Z in Patients with Uremia and Its Significance
Panahandeh G	-	Prothrombin G20210A and Factor V Leiden Mutations in Southern Iran
Pancaldi F	-	Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Panchenko E	-	Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions
	-	Relation of Changes in D-dimer and Factor VIIa Levels after Treatment with Heparins to Clinical Outcomes of Unstable Angina
Pandey M	-	Auto-Amplification of TNF-Alpha: A Potential Mechanism for the Maintenance of Elevated TNF-Alpha in Male But Not Female Obese Mice
Pandolfi A	-	MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin – A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes
Panduro L	-	Catheter Directed Thrombolysis of Acute Iliofemoral Deep Venous Thrombosis Is Effective and Preserves Venous Valve Function. Results from a Prospective One-centre Study of 60 Cases
Panes O	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
Panes O	-	Activated Human Platelets Synthesize Functional Tissue Factor
Panes O	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Panetti TS	-	Hic-5 Promotes Endothelial Cell Migration
Paneva D	-	Novel Materials Based on Chitosan or Chitosan Derivatives with Improved Blood Compatibility
Panfilov S	-	ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study
Pang A	-	Construction of a Phage Display Library of Human Fab Antibodies against Human Platelet Membrane Glycoprotein IIb/IIIa
Pang G	-	Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Paniccia R	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study
	-	Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests
	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
Panicot-Dubois L	-	Role of the Bile Salt Dependent Lipase (BSDL) in Thrombus Formation: in vitro and in vivo Study
Panicot-Dubois L	-	Calcium Mobilization Required for Firm Platelet Attachment is Dependent upon Both ADP and Thromboxane A2 during Thrombus Formation in a Living Mouse
	-	Molecular Pathways Involved in Thrombus Formation in vivo after FeCl3 or Laser-Induced Injury
Panizzi PR	-	Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury
Panteleev MA	-	Factor VIIIa Regulates Substrate Delivery to the Intrinsic Factor X-Activating Complex
Panteleev MA	-	Computer Simulation Model of Spatial Dynamics of Fibrin Clot Growth Under Conditions of Blood Flow
Panteleev MA	-	Two Subpopulations of Activated Platelets Differ in Their Binding of the Components of the Intrinsic fX-Activating Complex
Panyutina Y	-	Increase of Protein C Activity at Nephrotic Syndrome in Children
Panzer S	-	Antibodies Against the Human Platel et al. loantigen (HPA)-1a impair Cell Adhesion to Fibrinogen
Paoletti O	-	A Telemedicine Project for Managing Patients on Oral Anticoagulant Therapy
Paoletti V	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
Papadopoulos A	-	Haemophilic Arthropathy: Contribution of Clinical, X-Ray and MRI Scores in its Diagnosis and Modification of Treatment
Papagrigoriou E	-	Structural Studies of the Factor XI Dimeric Zymogen
Papagrigoriou V	-	Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
Papamichael ND	-	Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313–320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis
Papamichos SI	-	An Inquiry into Death Causes Based on Autopsy Findings
Papastavrou G	-	The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Papayan L	-	Hyperhomocysteinemia Is a Significant Risk Factor for Recurrent Early Pregnancy Loss in Russia
Papiewska I	-	Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit
Papp M	-	Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management
Paquette-Straub CA	-	Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties
Paradis B	-	Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm
Parapakpenjune S	-	Acute and Long Term Management for Patients with Severe Protein C Deficiency
Parapia LA	-	Homozygous Protein C Deficiency in an Affected Fetus – Is There a Case for Early Elective Delivery?
Parent F	-	Is It Safe to Withhold Anticoagulant Therapy in Patients with Negative Results on Spiral CT Pulmonary Angiography?
Parent F	-	Diagnostic Value of D-Dimer Assay in Patients with Suspected Pulmonary Embolism: Results in a Multicentre Outcome Study, the ESSEP Study (Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire)
Parent F	-	A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
	-	Deep Venous Thrombosis in Patients with Acute Pulmonary Embolism: Prevalence, Risk Factors and Clinical Significance
	-	Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
Pareyn I	-	Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody
	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
	-	False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease
	-	Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization
	-	Shielding of the A1-Domain by the Amino-Terminal Domain (AA764–1035) of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V
	-	Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing
	-	Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling
Parhami-Seren B	-	Activity and Content of Factor VIII in Various Factor VIII Products
Parhami-Seren B	-	Quantitation of FVIII Antigen in Human Plasma
Parise LV	-	Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation
Parise P	-	Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
Parise LV	-	Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins
Park T	-	Inhibitory Effects of Tirofiban on Platelet Function in Korean Patients During Percutaneous Coronary Intervention
Park E	-	Inhibitory Effects of Tirofiban on Platelet Function in Korean Patients During Percutaneous Coronary Intervention
Park T	-	Acute Inhibitory Effects of Glycoprotein IIb/IIIa Receptor Blockers on Platelet Function During Percutaneous Coronary Intervention
Park E	-	Acute Inhibitory Effects of Glycoprotein IIb/IIIa Receptor Blockers on Platelet Function During Percutaneous Coronary Intervention
Park JW	-	Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury
Park SDE	-	Accurate RNA Transcript Profiling of Platelets from Clinically Relevant, Small Blood Volumes
Park S	-	Thymidylate Synthase: A Possible Independent Risk Factor for Silent Brain Infarction
Park CJ	-	IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants
Park R	-	A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking
Parker ET	-	Characterization of Anti-Human and Anti-Porcine Factor VIII Monoclonal Antibodies Produced by Hemophilia A Mice
Parkh-Patel A	-	Rates of Venous Thromboembolism (VTE) in Californians with Cancer
Parmar N	-	Effect of Mechanical Ventilation on the Hemostatic State of the Newborn
Parmar K	-	Ex Vivo Studies of the Effect of Lupus Anticoagulant on Heparin Monitoring
	-	The Use of the Thromboelastograph and Rotem in Monitoring Recombinant Factor VIIa
Parodi RC	-	Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
Parrilla P	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
Parsi K	-	Prothrombotic Potential of Sclerosants: In Vitro Effects on Coagulation, Red cells and Platelets
Parton RG	-	The Palmitolyated Cysteine 595 Residue of PECAM-1 Is Required for Constitutive Association of PECAM-1 into Membrane Microdomains
Parvin A	-	Thromboembolic Disease and Its Relationship with ABO-Rh Blood-Groups and Other Variables in Patients at Warfarin Clinics in Iran
Pascual S	-	Optimisation of Ristocetin Cofactor Test for Low Activity Samples
Pascual M	-	Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus
Pasi J	-	A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Pasquet JM	-	A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
Pasqui AL	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Pasquier E	-	Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired Case–Control Study
Pasquier E	-	Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study)
Passera R	-	Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
	-	High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
Pastorelli M	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Patel A	-	Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke
Patel S	-	Platelet Shape and Formation
Patel RK	-	Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe
Patel B	-	Platelet Nitric Oxide Synthase (NOS) Is Negatively Regulated by Tyrosine Phosphorylation: A Novel Mechanism of eNOS Regulation
Patel H	-	Molar Specific Activity of Factor VIII: An Alternative Means of Comparing FVIII Concentrates
Patel RK	-	Prospective Study of the Diagnosis of Pulmonary Embolism (PE) Using Pretest Probability (PTP), D-Dimer (DD) and Appropriate Imaging
	-	Clinical and Laboratory Diagnosis of Heparin Induced Thrombocytopenia (HIT)
Patel H	-	Comparative Structural Analysis of Recombinant Factor VIII (rFVIII): Defining Full-Length FVIII
Patel S	-	Inhibition of Coagulation Cascade Enzymes by a Covalent Antithrombin-Heparin Complex
Patel P	-	Phospholipid Correction of Prolonged Kaolin Clotting Times. Validating the Diagnosis of a Lupus Anticoagulant
Paterson AD	-	Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study
Pathare AV	-	Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman
Pathare A	-	VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population
Pathare AV	-	Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman
Patricia P	-	Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets
Patrick G	-	Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
Patrono C	-	Insulin Resistance and Platelet Activation in Obese Women
	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
	-	Determinants of Platelet Activation in Alzheimer's Disease
Patruchev L	-	Homocystein and Hemostatic Variables in Young Postinfarction Patients
Patrushev LI	-	Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia
Patrusheva NL	-	Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia
Patsch JR	-	Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
	-	Inhibition of Monocyte-induced Procoagulant Activation with Antithrombin
Pattacini C	-	Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
	-	The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
Patterson C	-	Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study
PattersonO'Rear EEA	-	Reduced Bleeding Achieved through the Encapsulation of a Clot-busting Drug
Pattynama PMT	-	Right Ventricular Dysfunction and the Pulmonary Obstruction Index Assessed with Helical CT Predict Clinical Outcome During Three-month Follow-up in Patients with Acute Pulmonary Embolism
	-	Non-Invasive Diagnosis of Pulmonary Embolism Anno 2005
Pauer HU	-	Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo
Pauer HU	-	Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo
Paul AG	-	A New Method to Measure P2Y12 Receptor Expression on the Surface of Human Platelets: Effect of Clopidogrel
	-	The VASP Index: A New Reliable Method to Detect Response Variability after Clopidogrel
	-	High Platelet Reactivity is a Risk Factor for Post-Discharge Ischemic Complications Following Elective Coronary Stenting
Paule P	-	Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Paulmyer-Lacroix O	-	Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
Paulou E	-	References Values of roTEM Instrument
Pavanello R	-	Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients:  Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
Pavithra S	-	Independent Regulation of Platelet p38 MAP Kinase by the Collagen Receptor a2b1
Pavlova N	-	Effects of Hyperhomocysteinemia on the Anticoagulant System and Platelet Function Under Stress
Pavlova A	-	Thrombophilia in Inherited Antithrombin Deficiency
Pavlova E	-	Relationship Between Circulating Thrombomodulin Levels and Latent: Progression of Atherosclerosis in Type 2 Diabetic Patients
Pavlova N	-	Effect of Stress on Total Plasma Homocystein Concentration in Rats
Pavlova E	-	Relationship between Endothelial Haemostatic Markers in Type 2 Diabetic Patients
Pavlova N	-	Platelet Activation during Stress in Hyperhomocysteinemic Rats
Pavlova E	-	Significance of Low-Grade Inflammation Markers and Soluble Cell Adhesion Molecules in Patients with Type 2 Diabetes Mellitus
Pavlova N	-	Stress-Induced Platelet Activation in Hyperhomocysteinemic Rats
Pavlova B	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Pawlak K	-	Relationship Between Extrinsic Coagulation Pathway Activation and Metalloproteinase-2/TIMPs System in Hemodialysis Patients
Pawlak D	-	Relationship Between Extrinsic Coagulation Pathway Activation and Metalloproteinase-2/TIMPs System in Hemodialysis Patients
Pawlak D	-	Effect of Oxidative Stress on the Circulating Level of Type IV Collagenases and Their Inhibitors in Hemodialyzed Patients with Cardiovascular Disease
Pawlak K	-	Effect of Oxidative Stress on the Circulating Level of Type IV Collagenases and Their Inhibitors in Hemodialyzed Patients with Cardiovascular Disease
	-	Novel Determinants of Increased Plasma Tissue Factor Level in Maintenance Hemodialysis Patients
Pawlowska Z	-	Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells
Payne DA	-	Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin
Payne E	-	Recombinant VIIa in Uncontrolled Haemorrhage
Payne JH	-	Haemoperitoneum Associated with Ovulation in Women with Autosomal Recessive Bleeding Disorders
Payne CD	-	Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
Payne CD	-	Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
Paz B	-	Tissue Factor Is Expressed and Active on Cultured Human Trophoblast Cell Surface; Possible Regulation by Angiogenic Stimuli
Pchelina S	-	The Study of Genetics Risk Factors Predisposing to Myocardial Infarction in Young Men
Pchelina S	-	ABCA1 Transporter and Paraoxonase Gene Polymorphisms in Myocardial Infarction and Stroke
Peachey AR	-	GPVI-Dependent Binding of Murine Platelets to a Series of Triple-Helical Peptides Derived from Human Type III Collagen
Peake I	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
Peake IR	-	Does Type 1 VWD Exist
Peake I	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Peake IR	-	Possible Role for the Von Willebrand Factor Propeptide in Regulating Von Willebrand Factor Expression
Peake I	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Pearce AC	-	Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
Pearce AC	-	Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen
Pearl RG	-	Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo
Pears CJ	-	Comparison of the Role of Protein Kinase C (PKC) in Platelet Spreading on Fibrinogen and Collagen Related Peptide (CRP)
Pearse RJ	-	Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography
	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Pecci A	-	Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives
Pecci A	-	Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with -Related Disease
Pecheniuk NM	-	Venous Thrombosis in Males Is Associated with Dyslipoproteinemia Involving High Density Lipoprotein (HDL) Deficiency and Excess Low Density Lipoprotein (LDL)
Pecheniuk NM	-	Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis
Pecheniuk NM	-	Genotype Associations with Dyslipoproteinemia in Male Venous Thrombosis Patients
Pechik I	-	Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein
	-	The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily – LRP, VLDL and Megalin Receptors
	-	Molecular Mechanisms of Thrombin-Mediated Fibrin Assembly
Pecka M	-	Our Experiences with the Determination of ProC Global Test and with the Interpretation of Results
	-	Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
Pedersen RS	-	Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease
Peduto VA	-	Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System
Peerschke EIB	-	Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
Peeters M	-	Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation
Peetz D	-	The Role of Platelet Factor 4 and the Use of Dextran Sulfate in Anti Factor Xa Assays: Overestimation of Anticoagulant Activity in LMWH Therapy?
	-	Multicenter Evaluation of BCS® XP – A Further Development of the Widespread BCS® Coagulation Analyzer
	-	Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP)
	-	Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study
Peiretti S	-	Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
Peiretti F	-	The TNF Alpha Converting Enzyme (TACE/ADAM17) Is Expressed in the Atherosclerotic Lesion of ApoE-deficient Mice
Pekcelen Y	-	von Willebrand Disease Type 2N (Normandy) in Three Siblings
	-	Short-Course Use of Recombinant Factor VIIa in a Hemophilia Patient with Inhibitor Undergoing Cataract Surgeries
Pellegrini L	-	Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study
Pellequer JL	-	A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX
Pelli G	-	Atherosclerosis in LDLR Knock-Out Mice Immunized with b2GP1: Effect of High Cholesterol Diet and Pravastatin Supplementation
Penaloza A	-	Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
Pendu R	-	von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes
Pendurthi U	-	Proteolysis of CCN1 (Cyr61) by Plasmin: Functional Implications
Peng L	-	Haemostatic Characters during Liver Transplantation with Preoperative DIC
Peng Y-M	-	Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits
Peng JQ	-	The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells
Peng Q	-	RNA Interference Targeting Tissue Factor in a Murine Melanoma Metastasis Model
Pengo V	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
	-	The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
	-	The Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism. A Multicentre Prospective Cohort Study in 1626 Patients
Penka M	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Penka M	-	Treatment of Life Threatening Bleeding with rFVIIa in 2001–2004 in Czech Republic. Presentation of 126 Cases with the Help of ‘UniSeven’ Registry
Penke G	-	Antibodies Against the Human Platel et al. loantigen (HPA)-1a impair Cell Adhesion to Fibrinogen
Penner JA	-	The Older Hemophilia Patient with Inhibitors: Issues and Challenges
Pennings MTT	-	Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba
Penz S	-	Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque
Pepe G	-	Vitamin B6 Serum Level and Inflammation and in the InChianti Study
	-	C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
	-	Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
	-	Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
Peppelenbosch MP	-	Signal Transduction by Tissue Factor – An Unusual Cytokine Receptor
Peppelenbosch MP	-	Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation
	-	TF:FVIIa-Induced CREB Activation Occurs Via a Mechanism That Is Distinct from That Involved in TF:FVIIa-Induced STAT5 Activation
Pepperkok R	-	Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
Pereira J	-	Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
Pereira J	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Pereira ALM	-	Exploring New Molecules and Activities from Lonomia Obliqua Caterpillar Bristles Extract
Pereira J	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
	-	Activated Human Platelets Synthesize Functional Tissue Factor
Perelli Cippo P	-	Quality of Life (QoL) in Patients Receiving Vitamin K Antagonists (VKA): A Study Using EQ-5D Questionnaire
Perenovska P	-	Recombinant Factor VIIa – NovoSeven in Pediatric Practice
	-	Immune Thrombocytopenic Purpura in Childhood – Clinical and Immunologigal Investigations
Perez R	-	Factor VIII Inhibitors in Mild Haemophilia A. Incidence in Patients with Arg2150His Mutation in South of Spain
Pérez C	-	Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
Pérez-Ceballos E	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
	-	Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
Pérez-Montes R	-	Vein Trombosis in Pediatric Patients
Perez-Pujol S	-	Proteomic Analysis of Platelets and Platelet-Derived Microparticles by iTRAQ Labeling and Mass Spectrometry
Perfetto OS	-	Ten Year Experience of TKR in Hemophilic Patients: The Surgical Unsolved Problems
Pergantou H	-	Correlation of Various Mutations and Polymorphisms with the Risk of Thrombosis in Children
Pergantou H	-	Haemophilic Arthropathy: Contribution of Clinical, X-Ray and MRI Scores in its Diagnosis and Modification of Treatment
Pergantou H	-	Thromboembolic Episodes in Children: 15 years Experience from One Centre
Peri G	-	Pentraxin 3 in Patients with Pulmonary Embolism
Perkins SJ	-	The Factor XI Deficiency Database: An Interactive Web Database of Mutations, Phenotypes and Structural Analysis Tools
Perlati M	-	Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study
	-	A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
	-	The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study
Perneger T	-	The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched Case–Control ‘Big NOHA First’ Study
Pernod G	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
	-	Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status
	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
	-	Intracerabral Hematoma and Congenital Afibrinogenemia
Perreault S	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Perret-Guillaume C	-	Lupus Anticoagulants IgG with or without Anti-b2-Glycoprotein I Induced Acquired Activated Protein C Resistance Evidenced by Calibrated Automated Thrombography
Perrier A	-	Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score
	-	Differential Value of Risk Factors and Clinical Signs for the Diagnosis of Pulmonary Embolism in Suspected Patients According to Age
	-	Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cut-Off Value in Outpatients with Suspected Pulmonary Embolism
	-	Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
Perrin E	-	Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience
	-	A Comparison of Enoxaparin and Unfractionated Heparin in Combination with Tirofiban during Percutaneous Coronary Intervention: Effects on Inhibition of Coagulation
Perrotta PL	-	Platelets Express Steroidogenic 17b–hydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype
Perry DJ	-	The Factor XI Deficiency Database: An Interactive Web Database of Mutations, Phenotypes and Structural Analysis Tools
	-	A Novel Mutation in the Signal Peptide of the Antithrombin Gene
	-	Association of Estrogen Receptor-Alpha Gene Polymorphisms with Deep Vein Thrombosis; Results of the Mega Study
Perry SL	-	A Multi-Dose Pharmacokinetic Study of Dalteparin in Hemodialysis Patients
Perry DJ	-	Chromogenic and Fluorogenic Thrombin Generation Assays in Factor XI Deficiency: Correlation with Bleeding Phenotype
	-	Evaluation of Thirdwave Invader® DNA Analysis Compared to Multiplex PCR Analysis for the Detection of Factor VLeiden and Prothrombin 3'UTR Gene Mutations
Persson E	-	Characterization of a Novel Recombinant Factor VIIa Analog in a Cell-Based Model of Coagulation
	-	Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A
Persson KEM	-	Functional Analysis of the Factor Ix Egf-Like Domain Mutation Ile66thr Associated with Mild Hemophilia B
Persson E	-	Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion
Persson E	-	The Effect of Factor VIIa Gla Domain Removal on in vitro Factor X Activation
Persson E	-	Activation Hypothesis for Coagulation Factor VIIa
Perunicic J	-	Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
Perutelli P	-	Hemostatic Alterations in Pediatric Leukemias
Perzborn E	-	The Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation
Perzborn E	-	Inhibition of Platelet Glycoprotein Ib (GP Ib) by a Monoclonal Antibody Prevents Platelet Dependent Thrombosis in Mice
Perzborn E	-	Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
	-	Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications
	-	Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin
Pesavento R	-	Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls
	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
Pescara L	-	Determinants of Platelet Activation in Alzheimer's Disease
	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
Peshavariya H	-	Nitric Oxide Suppresses NADPH Oxidase-Dependent Superoxide Production in Human Endothelial Cells and Arteries
Pesonen EJ	-	Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation
Pestana JOM	-	Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss
Petäjä J	-	Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation
Peter K	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
	-	Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation
	-	A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule
	-	Design of Small Molecular Weight Activation-specific GPIIb/IIIa Inhibitors Based on the CDR3 Region of a Phage Display-derived Single-chain Antibody
	-	Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L)
	-	Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation
Peterková M	-	Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy
	-	Plasma TFPI Levels in Patients Undergoing Regular Hemodialysis and Treated with Erythropoietin
Petermann C	-	Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
Peternel P	-	Increased Haemostasis Potential Persists in Young Patients with Previous Ischemic Cerebrovascular Event
Peternel L	-	New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold – Antithrombotic Effect in Two Rat Venous Thrombosis Models
Peters M	-	Clinical Experience with Nadroparin in Pediatric Patients with Venous Thrombosis
Peters L	-	Outreach Anticoagulation Project For Injecting Drug Users With Deep Vein Thrombosis: A Randomised Controlled Trial
	-	Anaemia in Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT)
Peters RJG	-	Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation
Peters G	-	The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses
Peters L	-	Management of Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT): A Delphi Study
Peters M	-	Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family
Peters G	-	Monitoring of P2Y12 Receptor Antagonist Efficacy
Petersen LC	-	New Scintigraphic Method for Imaging of Gastro-intestinal Bleeding: Preliminary Results from Ex Vivo Studies in Rabbits
Petersen NE	-	Hemizygous Antithrombin-Deficiency Presenting with a Thrombosis at Birth
Petersen K-E	-	Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation
Petersen LC	-	Factor VIIa Binding and Internalization in Hepatocytes
Peterson M	-	Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study
Peterson JT	-	Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits
Petri-Fink A	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
Petrilli MP	-	Leukocyte Activation in Myeloproliferative Disease
Petrini P	-	Use of Helixate®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance
	-	Long-term Prophylaxis in VWD. The Swedish Experience
Petros S	-	Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy
	-	Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma
	-	Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation
	-	Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests
	-	Identifying the Bleeding Tendency in Patients with Hypo- and Dysfibrinogenemia
Petrov V	-	Idiopathic Thrombocytopenic Purpura at Children and Opportunistic Infections
Petrov V	-	Vaccinoassociated Acute Thrombocytopenic Purpura in Children
Petrova G	-	Prophylaxis for Hemophilia A and B – Present and Future
Petrova Y	-	PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies
	-	The Effect of Fibrin Degradation Products on Neuroendocrine Cells
Petrovan RJ	-	The Beige Mutation Is Atheroprotective in Apolipoprotein E-Deficient Mice
Petterson TM	-	Risk Factors for Venous Thromboembolism (VTE) Among Patients Hospitalized for Major Surgery: A Population-Based Case-Control Study
	-	Risk Factors for Venous Thromboembolism (VTE) among Patients Hospitalized for Acute Medical Illness: A Population-Based Case-Control Study
Petzinger J	-	Urokinase Receptor (uPAR)(CD87) – Clustering in Detergent Insoluble Adhesion Patches (DIAP) Leads to Cell Adhesion on a Vitronectin Matrix
Peypers EG	-	The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State
Peyvandi F	-	Ristocetin Accelerates Von Willebrand Factor (VWF) Hydrolysis Rate and Ameliorates Collagen Binding Assay (CBA) Sensitivity
	-	Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain
	-	Investigations of the Thrombin Generation Test in Patients with FV-L Mutation and Antiphospholipid Syndrome
	-	Relationship between CYP2C9 and VKORC1 Polymorphisms and Anticoagulant Dose Requirement
	-	Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis
	-	Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13
	-	Prothrombin G20210A and Factor V Leiden Mutations in Southern Iran
	-	Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations
Peyvandi F	-	Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF)
Peyvandi F	-	In vitro Expression Studies and Immunofluorescence Microscopy Analysis of Two Naturally Occurring Mutations on Factor X (FX) Gene (G94R And D95E)
Pfundt R	-	Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology
Pham H	-	Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
Philipp CS	-	Multi-Site Comparison of Platelet Function Testing
	-	Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders
	-	Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis
Philippides M	-	Pilot Study: Aspirin Resistance and/or Platelet Hypersensitivity in Cerebrovascular Disease
Philippou H	-	Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen)
	-	Molecular Mechanisms Involved in the Resistance of Fibrin to Clot Lysis in Subjects with Type 2 Diabetes Mellitus
Philips M	-	Cys570Ser Mutation in the von Willebrand Factor Propeptide in Recessive von Willebrand Disease
Phillips DJ	-	The CXCL 16 Chemokine Is Induced by Angiotensin II in the U-937 Human Monocytic-Derived Cell Line
Phillips RL	-	Identification of the Presence of Polymorphic Sites within Exon 28 of the von Willebrand Factor Gene Using Fluorescent SSCP
Phillips SA	-	Detection of Decreased GPIb Alpha Expression Using an Improved Flow Cytometric Assay in Pateints with an Inherited Macrothrombocytopenia and a Mild Clinical Phenotype
Phillips C	-	Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model
Phillips DR	-	Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study
Phillips S	-	Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice
	-	Clinical Measurements of Platelet Activation by Flow Cytometry Under Optimised Conditions
Pia R-MS	-	Independent Regulation of Platelet p38 MAP Kinase by the Collagen Receptor a2b1
Piacente L	-	Hemostatic Alterations in Pediatric Leukemias
Piazzón I	-	Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions
Pichard-Garcia L	-	Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes
Pichugin A	-	Comparison of Activated Platelets with Platelet-derived Microparticles in Procoagulant Activity
Pick M	-	Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation
Pickering W	-	Comparison of the Procoagulant Activity of T-Lymphoblastoid Cells with Fresh Platelets in Three Phospholipid Dependent Assays
Pidcock M	-	Successful Immune Tolerisation in an Adolescent Severe Haemophilia a Patient with an Inhibitor: A Case Report
Pidcock ME	-	Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature
Piechottka G	-	Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium
Piedimonte V	-	Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary
Pierangeli SS	-	Antiphospholipid Antibodies Impair the Clearance of Apoptotic Platelets
Pierangeli S	-	A Peptide Derived from Cytomegalovirus Reverses Antiphospholipid-Mediated Thrombosis by Displacing Binding of b2glycoprotein I to Endothelial Cells in Mice
Pierangeli S	-	Toll Like Receptor 4 Is Involved in Antiphospholipid-mediated Thrombosis: In vivo Studies
Pierangeli SS	-	A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis
Pierangeli S	-	Induction of Tolerance to b2Glycoprotein I in Mice
Pieroni G	-	Platelet Aggregation and ATP Release Values in Children and Adults
	-	Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
Pierscinska-Jedra M	-	Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
	-	Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
Piersma-Wichers M	-	Individual Time within Target Range (ITTR), an Accurate Predictor of Clinical Outcome in Patients with Acute Myocardial Infarction (AMI) Treated with Vitamin K Antagonists
	-	Risk of Thromboembolic Events and Major Bleeding in Patients Treated with Vitamin K Antagonists after Heart Valve Replacement (HVR); Individual Time within Target Range (ITTR) an Accurate Predictor
	-	Clinical Implications of Individual Time Within Target Range (ITTR) in Patients with Atrial Fibrillation (AF) treated with Vitamin K Antagonists
Pierson R	-	Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients
	-	Neurologic Injury during Ventricular Assist Device (VAD) Support: Association with Rebound Hypercoagulability after Heparin Withdrawal
Pietrapiana D	-	HGF Activates Its Met Receptor on Human Platelets and Inhibits Platelets Aggregation
Piette JC	-	Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
	-	Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers
Piffath CL	-	CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
Pignatelli P	-	Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients
Pignatelli P	-	Thrombus Growth Is Mediated by Gp91phox
Pignatti PF	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Pignoloni P	-	Different Reactivity of Factor VIII Inhibitor in Congenital and Acquired Haemophilia A
Pignoloni P	-	Central Venous Catheters Related Thrombosis in Hematological Patients
Pikalova Z	-	Determination of Platelet Derived Microparticles in Patients with Autoimmune Thrombocytopenia (AITP)
Pilia A	-	Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
Pilsgaard B	-	Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer
Pimanda JE	-	A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
	-	Thrombospondin as a Regulator of von Willebrand Factor Multimer Size
Pina E	-	Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy
	-	Study of the Prethrombotic State in Patients at High Risk of Developing Type 2 Diabetes Mellitus
Pineda J	-	Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
	-	Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
Pinelis V	-	PARs (Protease Activated Receptors) Activation by Thrombin and Factor Xa Protects Hippocampal Neurons against Glutamate-induced Apoptosis
Pini M	-	Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients:  Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients
	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Pinkoski L	-	The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Three European Blood Centers
Pinotti M	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
Pinotti M	-	Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
Pinton P	-	Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
Pio SF	-	Analysis of Factor VIII Gene Intron 1 Inversion in Brazilian Patients with Severe Haemophilia A
Piot M	-	Confirmation of the Pathogenic Role of Ig M and Ig A Anti Heparin-PF4 Antibodies in Patients with Heparin-Induced-Thrombocytopenia
Piovella F	-	Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
	-	The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients
	-	Extended Thromboprophylaxis with Fondaparinux (Arixtra®) after Major Orthopedic Lower Limb Surgery: The EXPERT Study
	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
	-	Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients:  Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Piovella F	-	High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
Piovella F	-	Use of Neuraxial Catheter for Anesthesia/Analgesia in Major Orthopedic Lower Limb Surgery Patients Treated With Prophylactic Doses of Fondaparinux (Arixtra®) in Routine Practice: The EXPERT Study
Piovella F	-	Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
Pipe SW	-	Factor VIII Expression Induces ER Stress Apoptosis In Cultured Cells and in Mice
Pipe SW	-	The Promise and Challenges of Bioengineered Recombinant Clotting Factors
Piqueras C	-	Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage
Piranda D	-	Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets
Pires V	-	TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts)
	-	Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
Piro P	-	Circulating Platelet-Monocyte Complexes Are Inversely Correlated with Serum Apo-A Levels
Piro D	-	Platelets Abolish the Profibrinolytic Effect of Heparin but not That of Melagatran
Piseddu G	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
Pistelli R	-	A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
Pitham T	-	Venous Thromboembolism and Spinal Surgery
Pithara E	-	Thrombophilic Mutations: A Comparison between the Microarray Technique and the Solid Phase Oligonucleotide Ligation Assay (SPOLA)
	-	Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs
	-	Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro
	-	Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT)
Pitterle K	-	The Annexin II Heterotetramer is a Receptor for the Plasmin-Induced Signaling in Human Peripheral Monocytes
Pixley RA	-	A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis
Pixton KL	-	Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Pizzolo F	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
PL Meroni	-	The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
Plahuta TG	-	Ulcerous Colitis in Children with Hemophilia A
	-	Family with Inherited f.X Deficiency. Case Report
	-	The Long-term Future of Patients Had Had Henoch-Schonlein Purpura in Childhood
Plaimauer B	-	Murine and Human ADAMTS13 Swap Mutants Shed a New Light on the Molecular Mechanism of the ADAMTS13-VWF Interaction
	-	Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA
Plaisance S	-	Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications
Plançon S	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
	-	A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch that Selectively Triggers Integrin aIIbb3-Dependent Cell Spreading, but not Cell Attachment
Planes A	-	Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
	-	High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
Plank C	-	Fibrin and b-chain Peptide (441–461) for Tissue Engineering Improves Tolerability and Efficiency of Non-viral Gene Vector Formulations
Plantier JL	-	Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability
Plantier J-L	-	Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage
Platokouki H	-	Haemophilic Arthropathy: Contribution of Clinical, X-Ray and MRI Scores in its Diagnosis and Modification of Treatment
	-	Thromboembolic Episodes in Children: 15 years Experience from One Centre
Platokouki H	-	Correlation of Various Mutations and Polymorphisms with the Risk of Thrombosis in Children
Platonova T	-	The Effect of Fibrin Degradation Products on Neuroendocrine Cells
Platteau C	-	Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
Plenina L	-	Activation of Fibrinolysis System at the Main Arterial and Venous Vessels Thrombosis with the Treatment of Gene-Engineering Thrombolythic Drug ‘Triasa’
Plesch W	-	INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins
Plesch W	-	Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing
Plesnila N	-	Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin
Ploos van Amstel JK	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
	-	Hemorrhagic risk in Female Carriers of Hemophilia
Plow EF	-	Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors
Plu-Bureau G	-	Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
Plu-Bureau G	-	Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration
Plu-Bureau G	-	Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis
Plug I	-	Hemorrhagic risk in Female Carriers of Hemophilia
Plumhoff EA	-	Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant
	-	Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing
Pluyshch T	-	Thrombin Induced Upregulation of Plasminogen Activator Inhibitor 1 (PAI-1) is Mediated by a Pathway Including S100 A9 Ca++ Binding Protein
Plyushch OP	-	Home Treatment of Patients with Hemophilia Using Clotting Factor Concentrates VIII and IX ‘Ahemphil A’ and ‘Ahemphil B’
Plyushch OP	-	Results of ‘Home Treatment’ for Patients with Using Factor VIII Concentrate ‘Hemoctin STD’
Plyushch OP	-	The National Register of Patients with Inherited Coagulopathies in Russia
PM Mannucci	-	The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
Pönitz V	-	Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI)
	-	Changes in Concentration of Specific Forms of Activated Factor XII Are Observed Following Thrombolytic Therapy with Tenecteplase
	-	Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction
Pock K	-	Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate
Podbregar M	-	Ultrasonic and Magnetic Resonance Characteristics of Pulmonary Emboli Ex Vivo
Podesta L	-	Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation
Podor TJ	-	The Effect of Thrombin Concentration on Fibrin Clot Structure Imaged by Multiphoton Microscopy and Quantified by Fractal Analysis
	-	Chimeric PAI-1-dsRed Fusion Protein Characterization and Expression in MEG-01 Megakaryocytic Cells: Model for PAI-1 Trafficking from a-Granules to Cell Surfaces
	-	Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy
Podorolskaya L	-	Coagulation and Anticoagulan Factors in Combined Action of Informational Overload and Weak Static Magnetic Field
Podorolskaya L	-	Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases
Poenitz V	-	Plasma Concentrations of Soluble Fibrin, D-dimer, Myeloperoxidase and Pregnancy Associated Plasma Protein A before and after Treatment with PCI or Thrombolysis for Acute Myocardial Infarction
Poetzsch B	-	Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia
Poggi M	-	Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
Poggi F	-	Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
Poggio R	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
Pogliani E	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
Pohlmann S	-	Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
	-	Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
Polack B	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
Polack B	-	Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status
	-	Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product
Polack B	-	Intracerabral Hematoma and Congenital Afibrinogenemia
Polack B	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Polack B	-	Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
Polenewen R	-	Platelet Function Analyser Is a Good Alternative for Classical Bleeding Time to Detect von Willebrand Disease and Thrombocytopathy
Polenewen RJ	-	Predictive Value of the Platelet Function Analyser (PFA-100®) for Post Biopsy Bleedings in Patients Undergoing Renal Biopsy
Polentarutti V	-	A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
Polgar J	-	CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
	-	Platelet Granule Secretion Mediates Platelet Aggregation and Thrombotic Arterial Occlusion
	-	Comparative Evaluation of FXIIIA and P-selectin Expression on the Surface of Thrombin-activated Platelets and Microparticles
Poli D	-	The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study
	-	Warfarin Therapy in AF Patients: Females Are Still at Risk
	-	High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
	-	Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
	-	Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk
Pollak E	-	Serologic Results in Suspected Heparin-Induced Thrombocytopenia
Pollard M	-	The Development of Transplanted Rat Prostate Tumors in vivo Is Impaired by Reduced Tissue Factor Expression
	-	Cancer Procoagulant Enhances Tumor Cell Adhesion to the Extracellular Matrix
Pollard D	-	Obstetric Experience of Carriers of Haemophilia
Pollmann H	-	Pharmacovigilance Evaluation with ReFacto®– 6 years Post-Licensure Experience With ReFacto®– Recombinant Factor VIII – in Germany and Austria
Pollmann H	-	ADVOY: First Experiences with an Internet Based Electronic System for Documentation of Haemophilia Therapy of Patients in Home Treatment
	-	Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene
	-	Home Treatment Diaries: Evaluation of a Handheld Communicator Brand Electronic System for the Documentation of Hemophilia Therapy
Pollola J	-	Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII
Polwart R	-	In vivo, Activated Factor XII Exists in Multiple Forms, but Predominantly as a 53 kD Species
	-	Changes in Concentration of Specific Forms of Activated Factor XII Are Observed Following Thrombolytic Therapy with Tenecteplase
	-	Detection of Activated Factor XII Associated with Blood Cells in Both FXII Normal and FXII Deficient Subjects
Polyantseva L	-	Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases
Pomar P	-	Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor
Pombo G	-	The Combination of LA with Antibodies to B2-Glycoprotein I (anti-B2GPI) and Prothrombin (anti-PT) Predicts a Higher Risk of Thrombosis
Pommereuil M	-	Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies
Pomp ER	-	Body Weight and Height, Obesity and Factor V Leiden. Risk of Venous Thrombosis in the Mega Study
Pong NH	-	The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice
	-	The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production
Pontara E	-	How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
	-	FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
Pontiggia L	-	Role of GPIb, GPIIb/IIIa and Shear on COAT-Platelets Formation
Pontzer J	-	Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study
Poole AW	-	PKCalpha Coordinates Syk and Src Signalling in Human Platelets
	-	Regulation of Platelet P2Y1 and P2Y12 Purinergic Receptor Internalization
Poon M-C	-	Treatment of Glanzmann's Thrombasthenia (GT): A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII (rFVIIa) and Other Hemostatic Agents
Popenko N	-	Comparison of Activated Platelets with Platelet-derived Microparticles in Procoagulant Activity
Popescu Gh	-	Arterial Thrombosis Complicating Limb Trauma
Popoff SN	-	A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression
Porcelijn L	-	The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria
Porciani MC	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Pornsri T	-	Homocysteine and Thrombosis in Thai Children: A Case-Control Study
Porreca E	-	Determinants of Platelet Activation in Alzheimer's Disease
Porro F	-	Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
	-	The Heparins and Cancer: Review of Clinical Trials and Biological Properties
Porte P	-	Evaluation of a New Manufacturing Process for Therapeutic Fibrinogen
Porter A	-	Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients
Porto E	-	Fibrinolytic Peritoneal Response to Laparoscopic Surgery
Pospisilova D	-	Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective Survey
Post M	-	Effect of Mechanical Ventilation on the Hemostatic State of the Newborn
Posthouwer D	-	Childhood Acquired Hepatitis C Infection in Patients with Hemophilia: A Cohort Study
Posthuma G	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
Postiglione A	-	Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary
Poston R	-	Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients
	-	Neurologic Injury during Ventricular Assist Device (VAD) Support: Association with Rebound Hypercoagulability after Heparin Withdrawal
	-	Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages
	-	An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions
Potaczek DP	-	The Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Effects of Quinapril and Atorvastatin on Haemostatic Parameters in Patients With Coronary Artery Disease
Potaczek D	-	Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study
Potti A	-	Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value
Pouplard C	-	Development of Non-pathogenic Antibodies to Platelet Factor 4 during Treatment by Fondaparinux after Hip Surgery
Pouzol P	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
	-	Intracerabral Hematoma and Congenital Afibrinogenemia
Powazniak Y	-	Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs
Powazniak Y	-	Partial Purification of ADAMTS-13
Powell JS	-	Treatment of Hemophilia Using Long-Term Venous Access Catheters: A Prospective Multicenter Clinical Trial
Poyarkov AA	-	Design and Synthesis of Peptides Modified by Chromone and Azauacil – Inhibitors of Thrombin
Poyarkova SA	-	Enhancement of Catalytic Activities of Thrombin and Trypsin By Human Insulin
Poyarkova SA	-	Study on Secondary Structure and Properties of Human Gamma-Thrombin
Poyarkova' SA	-	Design and Synthesis of Peptides Modified by Chromone and Azauacil – Inhibitors of Thrombin
Poz[zcaron]gajová M	-	Reduced Thrombus Stability in Mice Lacking the a2A-Adrenergic Receptor
Pozgajova M	-	Role of Integrin a2b1 in Thrombus Stabilization and Embolization
Pozgajová M	-	Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo
Pozner RG	-	Regulation of Megakaryocyte Generation by Monocytes/Macrophages
	-	Cyclic AMP Protects Stem Cell (CD34+) Apoptosis
Prabhakar J	-	P2Y12 Receptor – Mediated Thromboxane A2 Generation in Human Platelets Occurs in A GIRK – Dependent Manner
Prada F	-	Anticoagulation Therapy in the Osteonecrosis
Pradier O	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
Prager GW	-	Antiapoptotic Activity of Vascular Endothelial Growth Factor (VEGF) Is also Mediated by VEGF Induced Pro-urokinase (Pro-uPA) Activation
Praguywan K	-	Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake
Prampolini R	-	Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
Prandoni P	-	Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls
Prandoni P	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
Prandoni P	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
	-	Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis
Prandoni P	-	Which Patients Require Extended Secondary Prophylaxis?
Prandoni P	-	A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
	-	Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study
Prandoni P	-	Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study
Prandoni P	-	Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases
	-	The Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism. A Multicentre Prospective Cohort Study in 1626 Patients
Prandoni P	-	The Incidence of Heparin-Induced Thrombocytopenia in Medical Patients Treated with Low-Molecular-Weight Heparin: A Prospective Cohort Study
Prandoni P	-	Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study
	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
Prandoni P	-	High Versus Low Doses of Low-Molecular-Weight Heparin for the Treatment of Superficial Vein Thrombosis of the Legs. A Double-blind, Randomized Trial
Prasad UK	-	Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation
Prasad S	-	Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
Prat M	-	HGF Activates Its Met Receptor on Human Platelets and Inhibits Platelets Aggregation
Pratesi C	-	ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
Pratesi G	-	ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
Pratt KP	-	Mapping of B Cell Epitopes on the Factor VIII C2 Domain
Pratt J	-	Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature
Pratt KP	-	ELISA for Detecting Immune Responses to Factor VIII
Pratt K	-	Prevention of Anti-FVIII-C2 inhibitor formation Post Protein infusion in Hemophilic Mice By Prior Oral and/or Nasal Exposure of the FVIII-C2 Domain
	-	Disruption of an Immunogenic Epitope in the FVIII C2 Domain Results in the Prevention of Anti-FVIII-C2 Inhibitor Formation in BALB/c-FVIIIKO Hemophilic Mice
Praus M	-	Drugs with Anti-Prion Activity in Cell Culture Have Variable Effects on the Stimulation of Plasmin Generation by the Prion Protein NH2-terminal Fragment PrP23-110
Prayoonwiwat W	-	••
Prechel M	-	Consideration of HIT Antibody Isotype in Interpretation of the Serotonin Release Assay
	-	Arresting Platelet Activation Induced by HIT Antibodies Using a Desulfated Heparin
	-	Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT
Preda L	-	A New Automatic Method to Measure Adamts 13
Préda I	-	Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease
Preda L	-	An Innovative Method to Measure von Willebrand Factor Activity and Adamts13
	-	Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS)
Preiss A	-	Gene Polymorphisms of Hemostasis And Lipid Metabolism in Apparently Healthy Individuals from Southwest Germany
	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Preissner KT	-	Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo
	-	The Interaction of Factor VII Activating Protease (FSAP) with Growth Factors Influences Vascular Cell Proliferation and Migration
	-	Urokinase Receptor (uPAR)(CD87) – Clustering in Detergent Insoluble Adhesion Patches (DIAP) Leads to Cell Adhesion on a Vitronectin Matrix
	-	Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation
	-	Extracellular RNA Potentiates Factor VII Activating Protease (FSAP)–Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Induced by Platelet-Derived Growth Factor-BB (PDGF-BB)
	-	The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo
	-	The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP
	-	The Marburg I SNP (G511E) of Factor VII Activating Protease (FSAP), Which Is Linked to Atherothrombosis, Exhibits Diminished Proteolytic Activity
Prengler M	-	Recurrent Stroke: The Role of Prothrombotic Disorders
Prescott M	-	PIOPED Ventilation-perfusion Scan Reporting: The Inter-observer Variation
Pressley F	-	Assessment of Suspected Venous Thromboembolism in the UK: Findings from a Prospective Outpatient Treatment Registry (VERITY)
	-	Management of VTE in the Outpatient Setting: Findings from a UK Prospective Outpatient Treatment Registry (VERITY)
	-	Venous Thromboembolism Occurs Commonly Out-Of-Hospital in Patients Recently Immobilized through Surgery or Illness: Findings from the VERITY Outpatient Treatment Registry
Preston RJS	-	Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Preston FE	-	A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes
	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
	-	Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs – What Is the Truth?
	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
	-	The SSC/ISTH Secondary Coagulation Standard in UK NEQAS for Blood Coagulation Proficiency Testing Exercises: Assigned Values for FV:C and FXI:C Should Assist in the Standardisation of These Assays
Preston RJS	-	ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain
Pretelli P	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
Pérez-Casal M	-	Activated Protein C (APC) Bound to Microparticle-Associated Endothelial Protein C Receptor (EPCR) Occurs in vivo and Has Anticoagulant Properties
Pérez-Montes R	-	Hemostatic Abnormalities in Oncolgic Patients
Price P	-	Antibody to C1 Domain of Factor VIII Alters Interaction of Factor Xase Complex with Factor X
Price V	-	Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH)
Priepke H	-	Effect of Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate on the Bleeding Time in Anaesthetized Rats during Anticoagulant Treatment with the Direct Thrombin Inhibitor Dabigatran
	-	In Vitro Pharmacological Characterization of BIBT 986, A Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
	-	Anticoagulant, Anti-inflammatory and Organoprotective Effects of BIBT 986, a Novel Dual Inhibitor of Thrombin and Factor Xa, on LPS-induced Disseminated Intravascular Coagulation and Septicemia in the Rat
	-	In vivo Anticoagulant, Antithrombotic and Anti-inflammatory Efficacy of BIBT 986, a Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
Priesack J	-	Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
Priestley E	-	Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis
Prieto M	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
Primignani M	-	Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests
	-	Risk Factors for Thrombophilia in Extra-Hepatic Portal Vein Obstruction
Prins MH	-	Implication of Local Versus Independent Assessment of Reference Test for Accuracy of a Rapid Point-of Care Quantitative Assay for D-dimer (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
	-	Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis
	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
	-	Management Studies Using a Combination of D-Dimer Test Result and Clinical Probability to Rule Out Venous Thromboembolism; A Systematic Review
	-	Predictors of Recurrent Venous Thromboembolism. Balancing Benefits and Risks – A Decision Approach
	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
	-	Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis
	-	Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment
	-	The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT
	-	Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
PrinsBüller MHHR	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
Prisco D	-	Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
Prisco D	-	Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk
	-	Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
Prisco D	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Prisco D	-	Warfarin Therapy in AF Patients: Females Are Still at Risk
Prisco D	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
Prisco D	-	High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
	-	Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study
	-	eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
	-	The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study
Prisco D	-	Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests
Prisco D	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
Prisco D	-	Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
PriscoAbbate DR	-	More Carotid Atherosclerosis in HCV Positive Italian Patients?
Pritchard D	-	Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI)
Pritchard D	-	In vivo, Activated Factor XII Exists in Multiple Forms, but Predominantly as a 53 kD Species
Pritchard D	-	Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction
	-	Changes in Concentration of Specific Forms of Activated Factor XII Are Observed Following Thrombolytic Therapy with Tenecteplase
Pritchard D	-	Development and Evaluation of an Automated Immunoassay for the Determination of D-Dimer on the Abbott AxSYM® Analyzer
	-	Detection of Activated Factor XII Associated with Blood Cells in Both FXII Normal and FXII Deficient Subjects
Prochazka M	-	Prevalence of Inherited Thrombophilia in Severe OHSS
Pronk LM	-	Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis
Prosser I	-	Extensive Jugular and Subclavian Vein Thrombosis after Ovarian Hyperstimulation Syndrome as a Complication of In Vitro Fertilization: A Case Report
Prosser IW	-	Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature
Provan D	-	Anti-D Compared to IVIg for the Treatment of Immune Thrombocytopenic Purpura: A Systematic Review
Provenzano R	-	TAFI 325/Ile Genotype in Old Population of Northern Italy
Prow T	-	Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium
Pruthi R	-	The Impact of Symptom Duration on Plasma Fibrin D-Dimer Analysis in Deep Vein Thrombosis
Pruthi RK	-	Congenital Platelet ADP Receptor (P2Y12) Deficiency: A Case Report
Pruthi RK	-	Rituximab Treatment of FVIII Inhibitors in Congenital Hemophilia A (cHA)
Pruthi R	-	Natural History of Retinal Vein Thrombosis: Incidence of Local and Systemic Recurrence of Venous Thromboembolism
Pruthi RK	-	Post-splenectomy Mesenteric Vein Thrombosis: A Critical Analysis of Thrombocytosis as a Risk Factor
Prydz H	-	RNA Interference Targeting Tissue Factor in a Murine Melanoma Metastasis Model
Pryzdial ELG	-	The Effect of Factor Va on Prothrombin-Membrane Binding
Pryzdial E	-	Platelets Provide Factor IX (FIX) and Factor X (FX) to Support Dilute Tissue-factor Dependent Coagulation
PrzesmyckiK[ecedil]sik KJ	-	The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction
Przyklenk K	-	Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms
Przywara S	-	The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction
	-	Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD
Psaroulis D	-	An Inquiry into Death Causes Based on Autopsy Findings
Pszczolka M	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Obliterative Atherosclerosis
Pták J	-	A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura
	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Ptoszková H	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Puavilai T	-	Disseminated Intravascular Coagulation (DIC) in Medical Intensive Care Unit (ICU): Prevalence, Associated Conditions, and Prognostic Factors
Puccetti L	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Pudil R	-	Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
Pudur J	-	Loss of GATA-1 and Gain of FLI-1 Expression During Thrombocyte Maturation in Zebrafish
	-	Microarray Analysis of Prothrombin Knockdown in Zebrafish
	-	Evaluation of Gene Expression Profiles in Thrombocytes Using Microarrays
Pugatch T	-	Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
Pugin J	-	Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications
Pühringer H	-	Study of Genetic Risk Factors for Cardiovascular Disease in the Iranian Population by Means of Reverse-Hybridization Teststrips
Pula G	-	PKCalpha Coordinates Syk and Src Signalling in Human Platelets
	-	Regulation of Platelet P2Y1 and P2Y12 Purinergic Receptor Internalization
Pulcinelli FM	-	Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients
Pulcinelli FM	-	DAG Induces Ca2+ Influx through NCKX-TRPC Interaction, Independently of PKC Activity
	-	Collagen-Induced Platelet Shape Change Does Not Require Positive Feedback Activators and Is Insensitive to cAMP Elevating Agents
Puley G	-	The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation
Pulli R	-	ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
Puma F	-	Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer
Purdy G	-	Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
	-	Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment
	-	The Sensitive Detection of Antibodies to von Willebrand Factor Cleaving Protease (ADAMTS-13)
Purvis AR	-	Analysis of Free Thiols During Von Willebrand Factor Biosynthesis: Implications for the Oxidoreductase Mechanism of Multimerization
Pusateri AE	-	Effects of Hypothermia and Acidosis on Swine Platelet Activation and Aggregation in vivo
Pusateri AE	-	Effects of Acidosis and Hypothermia on Whole Blood Clotting Function in Swine
	-	Differential Effects of Acidosis and Hypothermia on Clot Development in Swine
Putter H	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
Putz G	-	The Additional Presence of Lupus Anticoagulants in 300 Patients with Anticardiolipin Antibodies Increases the Risk of Coincidental Venous and Arterial Thrombosis
Putz B	-	Is the Rate of Clinical Manifestations of the Antiphospholipid Syndrome Associated to Cumulative Findings of Antiphospholipid Antibodies?
	-	Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies
	-	Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome
	-	Clinical Significance of Antiphospholipid Antibodies in Haemophiliacs
Pyo HB	-	The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction